Geovax Labs Stock (NASDAQ:GOVX), Quotes and News Summary

Q: What sector and industry does Geovax Labs (GOVX) operate in?

Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Geovax Labs Stock (NASDAQ: GOVX) stock price, news, charts, stock research, profile.

Open	$1.635
Close	$1.500
Volume / Avg.	19.406K / 51.960K
Day Range	1.500 - 1.635
52 Wk Range	0.250 - 11.537
Market Cap	$3.670M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	0.29%
Days to Cover	1

Recent News

InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

GeoVax Labs And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

GeoVax Labs And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by around 69 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Geovax Labs Inc

Sector

Health Care

Industry

Biotechnology

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherap...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Geovax Labs (GOVX) stock?

You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.

View our list of the best stock brokerages.

Who are Geovax Labs's (GOVX) competitors?

Other companies in Geovax Labs’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).

What is the target price for Geovax Labs (GOVX) stock?

The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 8.00 expecting GOVX to rise to within 12 months (a possible 403.14% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Geovax Labs (GOVX)?

The stock price for Geovax Labs (NASDAQ: GOVX) is $1.59 last updated April 19, 2024 at 7:39 AM EDT.

Does Geovax Labs (GOVX) pay a dividend?

There are no upcoming dividends for Geovax Labs.

When is Geovax Labs (NASDAQ:GOVX) reporting earnings?

Geovax Labs’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Geovax Labs (GOVX) going to split?

There is no upcoming split for Geovax Labs.

What sector and industry does Geovax Labs (GOVX) operate in?

Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-